ArticleTissue engineering and regenerative medicine2025
Characteristics of 3D-Printed Polycaprolactone Tracheal Scaffolds Implanted In Vivo.
Article in Tissue engineering and regenerative medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Understanding Polycaprolactone Degradation: Molecular Mechanisms and Implications for Biomedical Device Design.Materials (Basel, Switzerland) · 2026Review
- Prevention of infectious complications in tracheal defects using a biodegradable polylactide patch: an experimental study.General thoracic and cardiovascular surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundA 3D-printing technology using polycaprolactone (PCL) has shown promise for the development of patient-customized tracheal constructs. However, no studies have compared the mechanical properties of various grades of PCL using animal experiments under the same conditions. In this study, the mechanical properties and tissue reconstruction abilities of research-grade (RG) and medical-grade (MG) PCL scaffolds were compared in rabbit tracheal defect models.
methodCustomized scaffolds for the rabbit's segmental defect was manufactured using an extrusion-based 3D printing system and two types of PCL. Six months after transplantation into trachea defected rabbits, transplanted areas were excised to evaluate its mechanical properties, and the reconstruction of the damaged tissue were analyzed through endoscope and tissue staining. And, the change in molecular weight of PCL before and after transplantation was compared using Gel permeation chromatography (GPC). Molecular weight changes PCL scaffolds before and after gamma radiation were also compared using GPC.
resultsThe medical-grade PCL scaffold (MG) group showed superior ultimate stress, strain, and tissue reconstruction compared with the research-grade PCL scaffold (RG) group, demonstrating better strength, ductility, and mucosal tissue regeneration. However, MG PCL scaffold degrades more rapidly in the body, as indicated by a notable decrease in molecular weight and ultimate stress post-transplantation. Gamma sterilization, which is an essential process for implants, did not affect the molecular weight of PCL, demonstrating its effectiveness in sterilization.
conclusionOur results highlight the substantial differences between RG and MG PCL scaffolds, emphasizing the need for researchers to thoroughly evaluate PCL properties before conducting animal studies or clinical trials to ensure the accurate prediction of experimental outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.